Poster Presentation Advances in Neuroblastoma Research Congress 2016

Non-random pattern of whole chromosome gains and losses in neuroblastoma with numerical chromosomal aberrations. (#192)

Ruben Van Paemel 1 , Tim Lammens 2 , Bram De Wilde 2 3 , Katleen De Preter 3 , Nadine Van Roy 3 , Geneviève Laureys 2
  1. Ghent University, Ghent, Belgium
  2. Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital (GHU), Ghent, Belgium
  3. Center of Medical Genetics Ghent, Ghent University, Ghent, Belgium

Introduction. In most types of adult cancer, aneuploidy leads to an unfavorable prognosis. In absence of segmental chromosomal alterations (SCA) infant neuroblastoma and low-risk tumors (INSS stage 1, 2, 4S) are frequently associated with hyperdiploidy or near-triploidy and have a clinical good prognosis. In pediatric acute lymphoblastic leukemia, hyperdiploidy is also associated with a good prognosis. The mechanisms leading to these types of genetic defects and associated good prognosis are poorly understood.

Methods. Array-CGH data from 96 neuroblastomas with only numerical chromosome alterations (NCA) were analyzed, using 68 cases from the R2 database (http://hgserver1.amc.nl/cgi-bin/r2/main.cgi) and 28 additional GHU cases.

Results. Analysis of the array-CGH confirmed a non-random pattern of whole chromosome gains and losses in NB with NCA only. The number of gains and losses was highly variable between the different tumors. In 14/96 tumors only chromosome gains were observed, 80/96 had a combination of gains and losses, in 2/96 tumors only loss of one chromosome was present. In tumors with gains (94/96), combination of chromosome 17 (n=87) and/or chromosome 6 and/or 7 gain was present in all cases (94/94). In 82/84 tumors with losses, these losses involved a combination of chromosome 14 (n=63), 11, 3, and 4. In tumors with gains and losses different combination patterns were seen. Chromosome 17 gain was accompanied by loss of 14 in 61/72 tumors, and with loss of chromosome 11/4/3 in 8/9 of the remaining cases. The 7 tumors without chromosome 17 gain always presented with a chromosome 6 or 7 gain and loss of chromosome 14.

Conclusion. In NB with NCA we found a typical pattern of combinations of gains of chromosomes 6/7/17 and losses of 3/4/11/14. As previously described, the typical segmental abnormalities present in tumors with SCAs involve the same chromosomes: 17q-gain, 3p/4p/11q/14q-deletions. Understanding the underlying pathophysiology requires further studies.